Ventana Medical Systems, a member of the Roche Group, has launched a new fully-automated staining technique that allows researchers to visualize miRNAs and proteins related to cancer in the same section of tumor tissue. Detection of ...
Tags: Ventana, staining technique, cancer detection, miRNAs
Ventana Medical Systems, a member of the Roche Group, has introduced a fully-automated staining technique, which helps researchers to examine miRNAs and proteins related to cancer in the same section of tumor tissue. Detecting miRNAs and ...
Tags: Ventana Medical Systems, miRNAs, proteins related to cancer
The USFDA has accepted Exelixis' new drug application for cabozantinib as a treatment for patients with progressive, unresectable, locally advanced, or metastatic medullary thyroid cancer and granted priority review designation. ...
Tags: FDA, new drug application, Priority Review Designation